26 percent of senior oncology patients use alternative therapies
the ONA take:
More than a quarter of senior oncology patients use complementary or alternative medicines (CAM), according to a study published in the Journal of Geriatric Oncology.
"Currently, few oncologists are aware of the alternative medicines their patients take," says Ginah Nightingale, PharmD, an Assistant Professor in the Jefferson College of Pharmacy at Thomas Jefferson University.
"Patients often fail to disclose the CAMs they take because they think they are safe, natural, nontoxic and not relevant to their cancer care, because they think their doctor will disapprove, or because the doctor doesn't specifically ask."
For the study, researchers surveyed senior patients with cancer who came for consultations at the Thomas Jefferson University Hospital Senior Adult Oncology Multi-Disciplinary clinic. Researchers found that 26% of patients were taking CAMs at some point during their cancer care. Of those, 68% were over 80 years of age and the majority of users were women.
The most common CAMs used by patients were alternative therapies for macular degeneration, probiotics, joint health, and mega-dose vitamins or minerals.
The finidngs suggest that it is very important that clinicians comprehensively screen older patients with cancer for all medications used, including CAMs. Certain CAMs like St. John's wort can interact with certain anti-cancer medications, making them less effective.
More than a quarter of senior oncology patients use complementary or alternative medicines (CAM).
Sign Up for Free e-newsletters
- Chemotherapy-Related Fatigue Linked to Levothyroxine Use in Breast Cancer
- New Hypertension Threshold Guides Blood Pressure Management During Cancer Treatment
- Sexual Aids and Resources Not Readily Available at Cancer Centers
- Gas Mixture Improves Efficacy of Breakthrough Cancer Pain Treatment
- Factors Affecting Employment Participation in Early-stage Breast Cancer
- Sitting With Silence in End-of-Life Cancer Care
- Obesity and Cancer Risk (Fact Sheet)
- Susceptibility Gene Mutations Common in Those With Pancreatic Cancer and History of Other Cancers
- Anticancer Properties of Omega-3 Fatty Acids: Plant-Based vs Marine-Based
- US Pharmacopeia Revises Chapter on Handling Hazardous Drugs
- Exercise Before Lung Cancer Surgery Greatly Reduces Complications
- Hodgkin Lymphoma Treatment in EU vs US: Similarities Would Enable Worldwide Studies
- Zinc Sulfate Improves Chemotherapy-Induced Mucositis Outcomes in Leukemia
- 5-Year Overall Survival in Endometrial Cancer Not Improved With Chemoradiotherapy
- Travel Distance to Prostate Cancer Treatment Influences Treatment Choice
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|